Tulus Abadi, chairman of the Indonesian Consumers Foundation (FKBI), said soaring medicine and vitamin prices were an unavoidable consequence of the rupiah’s depreciation, noting that between 85 and 90 per cent of the raw materials used by Indonesia’s pharmaceutical industry are imported.



